News

 

 

Clinical Trials

Marc Ernstoff
Professor
Immunology and Cancer Immunotherapy

  • Argos Therapeutics, Inc.
    An international Phase 3 randomized trial of autologous dendritic cell immunotherapy (AGS-003) plus standard treatment of advanced renal cell carcinoma (ADAPT)

Camilo E. Fadul
Professor
Immunology and Cancer Immunotherapy

  • In House
    Vaccination of patients with newly diagnosed glioblastoma using autologous tumor lysate and montanide emulsion for derivation of tumor specific hybridomas

Peter A. Kaufman
Associate Professor
Molecular Therapeutics

  • Genentech
    An observational cohort study of treatment patterns and outcomes in patients with HER2 positive (HER2+) metastatic breast cancer

J. Marc Pipas
Associate Professor
Molecular Therapeutics

  • UVM
    Effectiveness of aprepitant in addition to ondansetron in the prevention of nausea and vomiting caused by fractionated radiotherapy to the upper abdomen (AVERT)